Anbio Biotechnology (NNNN) Long-Term Deferred Tax (2023 - 2024)
Anbio Biotechnology's (NNNN) quarterly Long-Term Deferred Tax came in at $387440.0 in Q4 2024, up 804.49% year-on-year from $42835.0 in Q1 2024, and up 804.49% on a QoQ basis from $42835.0 in Q4 2023.
Anbio Biotechnology (NNNN) Long-Term Deferred Tax (2023 - 2024) Analysis & Trends
Anbio Biotechnology (NNNN) has 2 years of Long-Term Deferred Tax data on file, last reported at $387440.0 in Q4 2024.
- On a quarterly basis, Long-Term Deferred Tax rose 804.49% year-over-year to $387440.0 in Q4 2024; TTM through Dec 2024 was $387440.0, a 804.49% increase from a year earlier, with the FY2024 full-year figure at $387440.0, up 804.49% from the prior year.
- Long-Term Deferred Tax for Q4 2024 stood at $387440.0, up from $42835.0 in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for NNNN reached as high as $387440.0 in Q4 2024 and fell as low as $42835.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Anbio Biotechnology | 425.37 Mn | 413.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 387,440.00 |
| Dec 31, 2023 | 42,835.00 |